Development of rapid and high-throughput LC-MS/MS method for quantification of olprinone in rabbit plasma

被引:0
作者
Kertys, Martin [1 ,2 ]
Kosutova, Petra [2 ,3 ]
Mokra, Daniela [2 ,3 ]
Mokry, Juraj [1 ,2 ]
机构
[1] Comenius Univ, Jessenius Fac Med Martin, Dept Pharmacol, Mala Hora 4C, Martin 03601, Slovakia
[2] Comenius Univ, Jessenius Fac Med Martin, Biomed Ctr Martin, Martin, Slovakia
[3] Comenius Univ, Jessenius Fac Med Martin, Dept Physiol, Martin, Slovakia
关键词
liquid chromatography; mass spectrometry; olprinone; plasma; rabbit; PHOSPHODIESTERASE-III INHIBITOR; HYDROCHLORIDE;
D O I
10.1002/bmc.4620
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, highly sensitive and rapid method for quantification of olprinone (phosphodiesterase 3 inhibitor) in rabbit plasma using liquid chromatography-tandem mass spectrometry with electrospray was developed. An aliquot of 50 mu L of plasma sample was cleaned up and extracted using Ostro (TM) 96-well plate followed by dilution. Chromatographic separation of olprinone and olprinone-d3 was carried out on a CORTECS (R) T3 column within 3 min. Detection was achieved using a triple quadrupole mass spectrometer employing electrospray ionization operated in positive ion multiple reaction monitoring mode using the transitions m/z 251.07 -> m/z 155.06 and m/z 254.21 -> m/z 158.10 for olprinone and olprinone-d3, respectively. The method was validated according to US Food and Drug Administration guideline for bioanalytical methods, and showed excellent linearity in the range 10.0-2000.0 ng/mL with coefficient of determination >0.99. The intra- and inter-day precisions (CV) were <5.1% and the accuracies were within the range 99.7-103.2% at all quality control concentrations. Furthermore, olprinone was stable under various stability conditions. The developed method was used for quantification of olprinone in rabbit plasma after its intravenous administration at the dose of 1 mg/kg in order to better understand the metabolism of olprinone in a rabbit model of lung injury.
引用
收藏
页数:8
相关论文
共 19 条
[1]   Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use [J].
Bender, Andrew T. ;
Beavo, Joseph A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :488-520
[2]   Effects of dopamine and olprinone on ventricular energetics in sevoflurane-induced acute left ventricular depression in dogs [J].
Iwade, Motoyo ;
Nomura, Minoru ;
Uezono, Shoichi ;
Ashikari, Eri ;
Ozaki, Makoto .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2006, 20 (03) :358-363
[3]   Pretreatment with olprinone hydrochloride, a phosphodiesterase III inhibitor, attenuates lipopolysaccharide-induced lung injury via an anti-inflammatory effect [J].
Koike, Terumoto ;
Qutab, Muhammad Nadeen ;
Tsuchida, Masanori ;
Takekubo, Masaru ;
Saito, Masayuki ;
Hayashi, Jun-ichi .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2008, 21 (01) :166-171
[4]   EFFECTS OF PHOSPHODIESTERASE 5 INHIBITOR SILDENAFIL ON THE RESPIRATORY PARAMETERS, INFLAMMATION AND APOPTOSIS IN A SALINE LAVAGE-INDUCED MODEL OF ACUTE LUNG INJURY [J].
Kosutova, P. ;
Mikolka, P. ;
Balentova, S. ;
Kolomaznik, M. ;
Adamkov, M. ;
Mokry, J. ;
Calkovska, A. ;
Mokra, D. .
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 69 (05) :815-826
[5]  
Mizushige K, 2002, CARDIOVASC DRUG REV, V20, P163
[6]   Selective phosphodiesterase 3 inhibitor olprinone attenuates meconium-induced oxidative lung injury [J].
Mokra, Daniela ;
Drgova, Anna ;
Pullmann, Rudolf, Sr. ;
Calkovska, Andrea .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2012, 25 (03) :216-222
[7]  
Mokry J, 2008, J PHYSIOL PHARMACOL, V59, P473
[8]   Inhibitors of phosphodiesterases in the treatment of cough [J].
Mokry, Juraj ;
Urbanova, Anna ;
Kertys, Martin ;
Mokra, Daniela .
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2018, 257 :107-114
[9]   Bronchodilator effects of intravenous olprinone, a phosphodiesterase 3 inhibitor, with and without aminophylline in asthmatic patients [J].
Myou, S ;
Fujimura, M ;
Kamio, Y ;
Hirose, T ;
Kita, T ;
Tachibana, H ;
Ishiura, Y ;
Watanabe, K ;
Hashimoto, T ;
Nakao, S .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) :341-346
[10]   Differential pharmacologic sensitivities of phosphodiesterase-3 inhibitors among human isolated gastroepiploic, internal mammary, and radial arteries [J].
Onomoto, M ;
Tsuneyoshi, I ;
Yonetani, A ;
Suehiro, S ;
Matsumoto, K ;
Sakata, R ;
Kanmura, Y .
ANESTHESIA AND ANALGESIA, 2005, 101 (04) :950-956